| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 07/20/2011 | CN102127058A Pyrimidine derivatives for the treatment of abnormal cell growth |
| 07/20/2011 | CN102127056A Tubulin inhibitors |
| 07/20/2011 | CN102127030A 4-(substituted-1,3-dialkynyl)-4-(trifluoromethyl)benzo-1,4-dihydroxazole-2-one compounds and preparation method and applications thereof |
| 07/20/2011 | CN102127023A 7-membered ring compound, process for producing the same, and use thereof |
| 07/20/2011 | CN102126963A Spirobifluorene amido compound and preparation method thereof |
| 07/20/2011 | CN101312965B Morpholine type cinnamide compound |
| 07/20/2011 | CN101076519B Amide compound and thrombopoietin receptor activator |
| 07/19/2011 | US7982067 Phenethanolamine derivatives for treatment of respiratory diseases |
| 07/19/2011 | US7982043 Protein tyrosine kinase enzyme inhibitors |
| 07/19/2011 | US7982038 Ligands |
| 07/19/2011 | US7982037 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3 |
| 07/19/2011 | US7981900 2-phenyl pyrimidines which are tubulin inhibitors |
| 07/19/2011 | US7981889 e.g. 4-[5-(Piperidine-1-carbonyl)-furan-2-ylmethyl]-2H-phthalazin-1-one; enzyme poly(ADP-ribose)polymerase (synthase)-1 or poly ADP-ribosyltransferase (PARP-1) inhibitor; anticarcinogenic agent with BRCA2 deficient phenotype; septic shock; ischemic injury; hemorrhagic shock; multiple sclerosis |
| 07/19/2011 | US7981887 Therapeutic compounds |
| 07/19/2011 | US7981886 Antibiotics derivatives |
| 07/19/2011 | US7981883 Substituted spiro-compounds and the use thereof for producing medicaments |
| 07/19/2011 | US7981881 Fused heterocyclic compounds and use thereof |
| 07/19/2011 | US7981880 3-(aminomethyliden) 2-indolinone derivates and their use as cell proliferation inhibitors |
| 07/19/2011 | CA2485503C Phenyl-thiophene type vitamin d receptor modulators |
| 07/19/2011 | CA2472713C N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
| 07/19/2011 | CA2465691C 2-amino-4-heteroarylethyl thiazoline derivatives and their use an inhibitors of inducible no-synthase |
| 07/19/2011 | CA2344169C Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 07/19/2011 | CA2237590C Cyclic and heterocyclic n-substituted .alpha.-iminohydroxamic and -carboxylic acids |
| 07/14/2011 | WO2011085170A1 Fungicidal heterocyclic compounds |
| 07/14/2011 | WO2011084985A1 Cxcr3 receptor antagonists |
| 07/14/2011 | WO2011084962A1 Analogs of dehydrophenylahistins |
| 07/14/2011 | WO2011084796A2 Novel quinazoline derivatives |
| 07/14/2011 | WO2011084642A1 Compound suitable for the treatment of synucleopathies |
| 07/14/2011 | WO2011084098A1 Process for making a metabotropic glutamate receptor positive allosteric modulator - 874 |
| 07/14/2011 | WO2011082566A1 A fluorescent dye, its preparation method and use thereof |
| 07/14/2011 | WO2011031111A3 Alkoxy indole-3-acetic acid derivative acting as ppar α/γ/δ agonists, preparation method thereof, and pharmaceutical composition containing same as active ingredient |
| 07/14/2011 | US20110172434 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments |
| 07/14/2011 | US20110172415 Nitrogen-containing heterocycle derivatives substituted with cyclic group |
| 07/14/2011 | US20110172414 Isoxazoline compound and pesticide |
| 07/14/2011 | US20110172276 Carboxamide compound and use of the same |
| 07/14/2011 | US20110172272 Benzisoxazoles |
| 07/14/2011 | US20110172241 Benzazole analogues and uses thereof |
| 07/14/2011 | US20110172233 Sonic hedgehog modulators |
| 07/14/2011 | US20110172232 Aminoacyl prodrugs as an active pharmaceutical ingredient for thromboembolic disorders |
| 07/14/2011 | US20110172231 2,4- diaminopyrimidine derivatives |
| 07/14/2011 | US20110172230 Urea compound or salt thereof |
| 07/14/2011 | US20110172226 Novel hydrazide containing taxane conjugates |
| 07/14/2011 | US20110172225 Antifungal agents |
| 07/14/2011 | US20110172224 Novel heterocycles |
| 07/14/2011 | US20110172223 Substituted Aryl Sulfone Derivatives as Calcium Channel Blockers |
| 07/14/2011 | US20110172215 Benzene Sulfonamide Thiazole And Oxazole Compounds |
| 07/14/2011 | US20110172212 Amine-based compound and use thereof |
| 07/14/2011 | US20110172207 Substituted pyrazolamides and their use |
| 07/14/2011 | US20110172203 Substituted Imidazopyridinyl-Aminopyridine Compounds |
| 07/14/2011 | US20110172202 Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis |
| 07/14/2011 | US20110172174 Antibacterial agents |
| 07/14/2011 | US20110171569 Sulfonium derivatives and the use therof as latent acids |
| 07/14/2011 | US20110171171 Bridged secondary amines and use thereof as iap bir domain binding compounds |
| 07/14/2011 | CA2786327A1 Process for making a metabotropic glutamate receptor positive allosteric modulator - 874 |
| 07/14/2011 | CA2784744A1 Compound |
| 07/13/2011 | EP2343293A1 Novel piperidin-4-yl-thiazole-carboxamide analogues as inhibitors of t-cell proliferation and uses thereof |
| 07/13/2011 | EP2343282A1 Diaminopyrimidines as P2X3 and P2X2/3 antagonists |
| 07/13/2011 | EP2343069A1 Heterocyclic aspartyl protease inhibitors |
| 07/13/2011 | EP2342200A2 Compounds which selectively modulate the cb2 receptor |
| 07/13/2011 | EP2342199A2 Compounds which selectively modulate the cb2 receptor |
| 07/13/2011 | EP2342198A1 Salts of n-[6-cis-2,6-dimethylmorpholin-4yl)pyridine-3yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide |
| 07/13/2011 | EP2342181A1 Novel urea and thiourea derivatives |
| 07/13/2011 | EP2342178A1 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof |
| 07/13/2011 | EP2102197B1 5-([1,3,4]oxadiazol-2-yl)-1h-indazol and 5-([1,3,4]thiadiazol-2-yl)-1h-indazol derivatives as sgk inhibitors for the treatment of diabetes |
| 07/13/2011 | EP1697327B1 Insecticidal spiroindane derivatives |
| 07/13/2011 | EP1539717B1 Microbiocidal (e.g fungicidal) 1,2,3-triazole derivatives |
| 07/13/2011 | EP1432420B1 Benzimidazolidinone derivatives as muscarinic agents |
| 07/13/2011 | CN1989104B Cyclic amide derivatives, and their production and use as antithrombotic agents. |
| 07/13/2011 | CN1902193B Quinoxalines useful as inhibitors of protein kinases |
| 07/13/2011 | CN102124004A Azaindole inhibitors of iap |
| 07/13/2011 | CN102124003A Benzoxazinone derivatives acting as beta2-adrenoreceptor agonist for the treatment of respiratory disorders |
| 07/13/2011 | CN102124000A Pyridine compounds |
| 07/13/2011 | CN102123998A Isoquinolinone derivatives as nk3 antagonists |
| 07/13/2011 | CN102123991A 2 -arylaminoquinazolines for treating proliferative diseases |
| 07/13/2011 | CN102123990A Heterocyclic compound and use thereof |
| 07/13/2011 | CN102123988A Squaric acid derivatives as inhibitors of the nicotinamide |
| 07/13/2011 | CN102120741A Production method of an optically active compound |
| 07/13/2011 | CN102120740A Imidazoline compound chirally synthesized by using thiourea catalyst derived from rosin and application thereof in anti-inflammatory and antipyretic aspects |
| 07/13/2011 | CN101220002B Oxazolidinone compound as antimicrobial |
| 07/13/2011 | CN101190917B 3,4-dihydro-3-methyl-4-oxomidazo[5,1-d]-1,2,3,5-tetrazine-8-formic acid benzenesulfonyl furoxan esters compound, preparation method and use thereof |
| 07/12/2011 | US7977671 Compound having oxadiazole ring structure substituted with pyridyl group and organic electroluminescence device |
| 07/12/2011 | US7977480 Synthesis of paliperidone |
| 07/12/2011 | US7977477 Benzimidazole derivatives and their use as protein kinase inhibitors |
| 07/12/2011 | US7977466 C-glycoside derivatives and salts thereof |
| 07/12/2011 | US7977374 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (HDAC) inhibitors |
| 07/12/2011 | US7977371 Pyrrole derivative having ureido group and aminocarbonyl group as substituents |
| 07/12/2011 | US7977360 Benzo[d]isoxazol-3-yl-amine compounds and their use as vanilloid receptor ligands |
| 07/12/2011 | US7977356 Optical isomers of an Iloperidone metabolite |
| 07/12/2011 | US7977341 For crops; 3-(2,6-Dichlorophenyl)-4-[(3-pyridyl)hydroxymethyl]-5-trimethylsilylisoxazole for example |
| 07/12/2011 | US7977334 N-(3-{2-[3-(6-amino-benzimidazol-1-yl)-1,1-dimethyl-propylamino]-1-hydroxy-ethyl}-phenyl)-benzenesulphonamide; beta(3)-Adrenoceptor agonists; antidiabetic, obesity modulator, insulin resistance |
| 07/12/2011 | US7977333 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 07/12/2011 | US7977332 Insecticidal N-(heteroarylalkyl)alkanediamine derivatives |
| 07/12/2011 | US7977328 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes |
| 07/12/2011 | US7977322 Such as 1-Benzo[1,3]dioxol-5-yl-cyclopropanecarboxylic acid [5-(2-methoxy-pyridin-3-ylmethyl)-thiazol-2-yl]-amide 5-(2-Methoxy-pyridin-3-ylmethyl)-thiazol-2-ylamine; cystic fibrosis transmembrane conductance regulator disorders |
| 07/12/2011 | US7977057 Detection of immobilized nucleic acid |
| 07/12/2011 | CA2679198C Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases |
| 07/12/2011 | CA2588398C Potassium salt of an hiv integrase inhibitor |
| 07/12/2011 | CA2585053C Substituted n-acyl (hetero)aryl compounds as c-fms kinase inhibitors |
| 07/12/2011 | CA2517629C Phthalazinone derivatives |
| 07/12/2011 | CA2516699C Hiv replication inhibiting pyrimidines and triazines |